M. Zeviani et al., Deletions of mitochondrial DNA in Kearns-Sayre syndrome (Reprinted from Neurology, vol 38, pg 1339-1346, 1988), NEUROLOGY, 51(6), 1998, pp. 1339-1346
We have identified large-scale deletions in muscle mitochondrial DNA (mtDNA
) in seven of seven patients with Kearns-Sayre syndrome (KSS). We found no
detectable deletions in the mtDNA of ten non-KSS patients with other mitoch
ondrial myopathies or encephalomyopathies, or three normal controls. The de
letions ranged in size from 2.0 to 7.0 kb, and did not localize to any sing
le region of the mitochondrial genome. The proportion of mutated genomes in
each KSS patient ranged from 45% to 75% of total mtDNA. There was no corre
lation between the size or site of the deletion, biochemical abnormality of
mitochondrial enzymes, or clinical severity. The data bolster arguments th
at KSS is a unique disorder and genetic in origin.